insights_auto
Why is ARX down 2.97%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$0.49
arrow_downward
-2.97%(-0.015) 1D
Nov 19, 4:10:03 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.49
High
A$0.51
Low
A$0.49
Mkt. cap
167.83M
Avg. vol.
259.34K
Volume
245.68K
P/E ratio
46.67
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.49
High
A$0.51
Low
A$0.49
Mkt. cap
167.83M
Avg. vol.
259.34K
Volume
245.68K
P/E ratio
46.67
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
ChartMill
·
40 minutes ago
Most-Active S&P 500 Stocks: Ford, Super Micro, Pfizer Lead Session Volume
TradingView
·
2 hours ago
Anthropic Jumps 27% in Record Debut, S&P 500 Eyes Sixth Straight Loss: Stock Market Today
The Motley Fool
·
1 hour ago
The S&P 500 Is Flashing Warning Signs. Here's Why Long-Term Investors Should Stay the Course.
Traders Union
·
26 minutes ago
Sam Ro: Nvidia nears 25th anniversary of S&P 500 inclusion
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd